Soligenix Stock Today

SNGX Stock  USD 0.43  0.01  2.27%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Over 83

 
High
 
Low
Very High
Soligenix is trading at 0.43 as of the 23rd of April 2024; that is -2.27 percent decrease since the beginning of the trading day. The stock's open price was 0.44. Soligenix has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Soligenix are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of June 2023 and ending today, the 23rd of April 2024. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
15th of June 1987
Category
Healthcare
Classification
Health Care
Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. Soligenix, Inc. was incorporated in 1987 and is headquartered in Princeton, New Jersey. Soligenix operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 10.52 M outstanding shares of which 115.8 K shares are at this time shorted by private and institutional investors with about 1.07 trading days to cover. More on Soligenix

Moving together with Soligenix Stock

  0.8EGRX Eagle PharmaceuticalsPairCorr
  0.77JNJ Johnson Johnson Aggressive PushPairCorr

Moving against Soligenix Stock

  0.61ELYM Eliem TherapeuticsPairCorr

Soligenix Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Soligenix's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Soligenix or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Chairman, CEO and PresChristopher Schaber
Business ConcentrationBiotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors)
Average Analyst Recommendation
Analysts covering Soligenix report their recommendations after researching Soligenix's financial statements, talking to executives and customers, or listening in on Soligenix's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Soligenix. The Soligenix consensus assessment is calculated by taking the average forecast from all of the analysts covering Soligenix.
Soligenix's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Soligenix's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Soligenix's financial leverage. It provides some insight into what part of Soligenix's total assets is financed by creditors.
By using current balance sheet information, investors can analyze the liability, assets, and equity on Soligenix's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Soligenix deploys its capital and how much of that capital is borrowed.
Liquidity
Soligenix cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company currently holds 3.49 M in liabilities with Debt to Equity (D/E) ratio of 2.44, implying the company greatly relies on financing operations through barrowing. Soligenix has a current ratio of 2.31, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Soligenix until it has trouble settling it off, either with new capital or with free cash flow. So, Soligenix's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Soligenix sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Soligenix to invest in growth at high rates of return. When we think about Soligenix's use of debt, we should always consider it together with cash and equity.

Net Income

(6.45 Million)
Soligenix (SNGX) is traded on NASDAQ Exchange in USA. It is located in 29 Emmons Drive, Princeton, NJ, United States, 08540 and employs 13 people. Soligenix is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 4.54 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Soligenix's market, we take the total number of its shares issued and multiply it by Soligenix's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Soligenix conducts business under Biotechnology sector and is part of Health Care industry. The entity has 10.52 M outstanding shares of which 115.8 K shares are at this time shorted by private and institutional investors with about 1.07 trading days to cover. Soligenix currently holds about 20.16 M in cash with (8.6 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.47, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Soligenix Probability Of Bankruptcy
Ownership Allocation
Soligenix maintains a total of 10.52 Million outstanding shares. About 96.0 % of Soligenix outstanding shares are held by general public with 0.1 (%) owned by insiders and only 3.6 % by institutional holders. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Soligenix Ownership Details

Soligenix Stock Price Odds Analysis

Based on a normal probability distribution, the odds of Soligenix jumping above the current price in 90 days from now is roughly 97.0%. The Soligenix probability density function shows the probability of Soligenix stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 1.4736. This usually implies as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Soligenix will likely underperform. Additionally, soligenix has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
  Odds Below 0.43HorizonTargetOdds Above 0.43
3.43%90 days
 0.43 
96.55%
Based on a normal probability distribution, the odds of Soligenix to move above the current price in 90 days from now is roughly 97.0 (This Soligenix probability density function shows the probability of Soligenix Stock to fall within a particular range of prices over 90 days) .

Soligenix Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Soligenix that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Soligenix's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Soligenix's value.
InstituionRecorded OnShares
Global Retirement Partners, Llc.2023-12-31
800
Glassman Wealth Services2023-12-31
211
Wells Fargo & Co2023-12-31
76.0
Scarborough Advisors, Llc2023-12-31
62.0
Advisor Group Holdings, Inc.2023-12-31
53.0
Goss Wealth Management Llc2023-12-31
48.0
Bank Of America Corp2023-12-31
19.0
Albion Financial Group (utah)2023-12-31
5.0
Royal Bank Of Canada2023-09-30
3.0
Renaissance Technologies Corp2023-12-31
92.8 K
Blackrock Inc2023-12-31
80.7 K
View Soligenix Diagnostics

Soligenix Historical Income Statement

Soligenix Income Statement is one of the three primary financial statements used for reporting Soligenix's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Soligenix revenue and expense. Soligenix Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Soligenix's Depreciation And Amortization is fairly stable compared to the past year. Interest Expense is likely to rise to about 76.7 K in 2024, whereas Selling General Administrative is likely to drop slightly above 4.3 M in 2024. View More Fundamentals

Soligenix Stock Against Markets

Picking the right benchmark for Soligenix stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Soligenix stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Soligenix is critical whether you are bullish or bearish towards Soligenix at a given time. Please also check how Soligenix's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Soligenix without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Comparator Now

   

Portfolio Comparator

Compare the composition, asset allocations and performance of any two portfolios in your account
All  Next Launch Module

Soligenix Corporate Directors

Soligenix corporate directors refer to members of a Soligenix board of directors. The board of directors generally takes responsibility for the Soligenix's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Soligenix's board members must vote for the resolution. The Soligenix board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Jerome ZeldisIndependent DirectorProfile
Marco BrugheraDirectorProfile
Gregg LapointeIndependent DirectorProfile
Keith BrownlieIndependent DirectorProfile

How to buy Soligenix Stock?

Before investing in Soligenix, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Soligenix. To buy Soligenix stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Soligenix. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Soligenix stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Soligenix stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Soligenix stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Soligenix, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Soligenix Stock please use our How to Invest in Soligenix guide.

Already Invested in Soligenix?

The danger of trading Soligenix is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Soligenix is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Soligenix. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Soligenix is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Soligenix offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Soligenix's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Soligenix Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Soligenix Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Soligenix. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
For more information on how to buy Soligenix Stock please use our How to Invest in Soligenix guide.
Note that the Soligenix information on this page should be used as a complementary analysis to other Soligenix's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Complementary Tools for Soligenix Stock analysis

When running Soligenix's price analysis, check to measure Soligenix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Soligenix is operating at the current time. Most of Soligenix's value examination focuses on studying past and present price action to predict the probability of Soligenix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Soligenix's price. Additionally, you may evaluate how the addition of Soligenix to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Transaction History
View history of all your transactions and understand their impact on performance
Stocks Directory
Find actively traded stocks across global markets
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Is Soligenix's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Soligenix. If investors know Soligenix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Soligenix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.79)
Revenue Per Share
0.108
Quarterly Revenue Growth
(0.33)
Return On Assets
(0.40)
Return On Equity
(237.84)
The market value of Soligenix is measured differently than its book value, which is the value of Soligenix that is recorded on the company's balance sheet. Investors also form their own opinion of Soligenix's value that differs from its market value or its book value, called intrinsic value, which is Soligenix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Soligenix's market value can be influenced by many factors that don't directly affect Soligenix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Soligenix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Soligenix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Soligenix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.